CA3171473A1 - Compounds and methods of use - Google Patents
Compounds and methods of useInfo
- Publication number
- CA3171473A1 CA3171473A1 CA3171473A CA3171473A CA3171473A1 CA 3171473 A1 CA3171473 A1 CA 3171473A1 CA 3171473 A CA3171473 A CA 3171473A CA 3171473 A CA3171473 A CA 3171473A CA 3171473 A1 CA3171473 A1 CA 3171473A1
- Authority
- CA
- Canada
- Prior art keywords
- membered
- carboxamide
- naphthyridin
- dimethoxy
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062980954P | 2020-02-24 | 2020-02-24 | |
| US62/980,954 | 2020-02-24 | ||
| US202063121418P | 2020-12-04 | 2020-12-04 | |
| US63/121,418 | 2020-12-04 | ||
| PCT/US2021/019294 WO2021173591A1 (en) | 2020-02-24 | 2021-02-23 | Compounds and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3171473A1 true CA3171473A1 (en) | 2021-09-02 |
Family
ID=74885066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3171473A Pending CA3171473A1 (en) | 2020-02-24 | 2021-02-23 | Compounds and methods of use |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230151003A1 (https=) |
| EP (1) | EP4110779A1 (https=) |
| JP (1) | JP2023514725A (https=) |
| CN (1) | CN115605478A (https=) |
| AU (1) | AU2021226747A1 (https=) |
| CA (1) | CA3171473A1 (https=) |
| WO (1) | WO2021173591A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022551422A (ja) | 2019-09-26 | 2022-12-09 | エグゼリクシス， インコーポレイテッド | ピリドン化合物およびタンパク質キナーゼの調節における使用の方法 |
| CA3211063A1 (en) | 2021-02-19 | 2022-08-25 | Exelixis, Inc. | Pyridone compounds and methods of use |
| CN117343046A (zh) * | 2023-09-25 | 2024-01-05 | 辽宁大学 | 一种新型3-氧代-4-取代芳基-3,4-二氢吡嗪-2-甲酰胺类化合物及其应用 |
| CN118878515B (zh) * | 2024-06-19 | 2025-10-28 | 河北科技大学 | 一种取代苯胺嘧啶类化合物及其制备方法和用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
| US4326525A (en) | 1980-10-14 | 1982-04-27 | Alza Corporation | Osmotic device that improves delivery properties of agent in situ |
| US5364620A (en) | 1983-12-22 | 1994-11-15 | Elan Corporation, Plc | Controlled absorption diltiazem formulation for once daily administration |
| US5023252A (en) | 1985-12-04 | 1991-06-11 | Conrex Pharmaceutical Corporation | Transdermal and trans-membrane delivery of drugs |
| US5001139A (en) | 1987-06-12 | 1991-03-19 | American Cyanamid Company | Enchancers for the transdermal flux of nivadipine |
| US4992445A (en) | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
| US4902514A (en) | 1988-07-21 | 1990-02-20 | Alza Corporation | Dosage form for administering nilvadipine for treating cardiovascular symptoms |
| JO2787B1 (en) * | 2005-04-27 | 2014-03-15 | امجين إنك, | Alternative amide derivatives and methods of use |
| CN104072480B (zh) * | 2013-03-27 | 2016-12-28 | 沈阳药科大学 | 喹啉类化合物及其制备方法和应用 |
| TWI649308B (zh) * | 2013-07-24 | 2019-02-01 | 小野藥品工業股份有限公司 | 喹啉衍生物 |
| CN105461687B (zh) * | 2014-08-26 | 2020-06-19 | 北京京奉医药科技有限公司 | 含二氢哒嗪酮的喹啉类化合物及其用途 |
| ES2749726T3 (es) * | 2014-12-25 | 2020-03-23 | Ono Pharmaceutical Co | Derivado de quinolina |
| CN109896997A (zh) * | 2017-12-08 | 2019-06-18 | 中国药科大学 | N－酰基苯胺类c－Met激酶抑制剂的制备方法及其用途 |
| CN110330479A (zh) * | 2019-07-19 | 2019-10-15 | 南京华威医药科技集团有限公司 | 一种用作axl抑制剂的抗肿瘤化合物及其用途 |
-
2021
- 2021-02-23 JP JP2022550164A patent/JP2023514725A/ja not_active Withdrawn
- 2021-02-23 EP EP21712651.5A patent/EP4110779A1/en active Pending
- 2021-02-23 US US17/800,084 patent/US20230151003A1/en active Pending
- 2021-02-23 WO PCT/US2021/019294 patent/WO2021173591A1/en not_active Ceased
- 2021-02-23 AU AU2021226747A patent/AU2021226747A1/en not_active Abandoned
- 2021-02-23 CA CA3171473A patent/CA3171473A1/en active Pending
- 2021-02-23 CN CN202180030581.1A patent/CN115605478A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023514725A (ja) | 2023-04-07 |
| US20230151003A1 (en) | 2023-05-18 |
| EP4110779A1 (en) | 2023-01-04 |
| AU2021226747A1 (en) | 2022-09-01 |
| CN115605478A (zh) | 2023-01-13 |
| WO2021173591A1 (en) | 2021-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12371428B2 (en) | Pyridone compounds and methods of use | |
| JP7207629B2 (ja) | Ｒａｆキナーゼおよび／またはＲａｆキナーゼの二量体阻害剤としての縮合三環式ウレア系化合物 | |
| EP3013797B1 (en) | Fused tricyclic amide compounds as multiple kinase inhibitors | |
| CA3171473A1 (en) | Compounds and methods of use | |
| JP6767875B2 (ja) | Ｔｇｆ−ベータ阻害剤としての２，３−二置換ピリジン化合物および使用方法 | |
| JP6026427B2 (ja) | 置換６，６−縮合窒素複素環化合物及びその使用 | |
| EP4294804B1 (en) | Pyridone compounds and methods of use | |
| CN102224152B (zh) | 吡唑并吡啶pi3k抑制剂化合物及使用方法 | |
| CN107531693A (zh) | 作为吲哚胺2，3‑二加氧酶和/或色氨酸2，3‑二加氧酶抑制剂的新颖的5或8‑取代的咪唑并[1，5‑a]吡啶 | |
| JP7384536B2 (ja) | キナゾリン化合物並びにその調製方法、使用及び医薬組成物 | |
| EP3221318B1 (en) | Fused imidazole derivatives as tgf-beta inhibitors | |
| JP2014051516A (ja) | タンパク質キナーゼ阻害剤として有用な５−シアノ−４−（ピロロ［２，３ｂ］ピリジン−３−イル）−ピリミジン誘導体 | |
| JP2013503194A (ja) | Ｒａｆキナーゼを阻害するための１Ｈ−ピラゾロ［３，４−Ｂ］ピリジン化合物 | |
| JP2025517733A (ja) | ヘテロアレーン、それを含む医薬組成物、及びその使用方法 | |
| CA3187514A1 (en) | Fused bicyclic raf inhibitors and methods for use thereof | |
| CN121127472A (zh) | 蛋白质精氨酸酶甲基转移酶-5抑制剂及其医药用途 | |
| CN117440951A (zh) | 吡啶酮化合物和使用方法 | |
| KR20160040182A (ko) | 다중 키나제억제제인 융합된 트리사이클릭 아미드 화합물 | |
| HK1174038A (en) | 1h-pyrazolo [ 3, 4-b] pyridine compounds for inhibiting raf kinase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20250826 |
|
| U13 | Renewal or maintenance fee not paid |
Free format text: ST27 STATUS EVENT CODE: N-1-6-U10-U13-U300 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: DEEMED ABANDONED - FAILURE TO RESPOND TO MAINTENANCE FEE NOTICE Effective date: 20251027 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260202 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260407 |